Rock Springs Capital Management LP
100 holdingsFiling period: 2026-03-31Current AUM: $1.97Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | RVMD | REVOLUTION MEDICINES INC | 1.21M | $117.6M | $226.8M | 11.51% | -125,805 | 2026-03-31 |
| 2 | LLY | ELI LILLY & CO | 98.7K | $90.8M | $113.4M | 5.75% | -6,700 | 2026-03-31 |
| 3 | MDGL | MADRIGAL PHARMACEUTICALS INC | 171.0K | $89.5M | $79.9M | 4.06% | +31.4K | 2026-03-31 |
| 4 | MIRM | MIRUM PHARMACEUTICALS INC | 811.3K | $74.9M | $86.0M | 4.36% | +49.0K | 2026-03-31 |
| 5 | ARGX | ARGENX SE | 98.5K | $71.9M | $84.1M | 4.27% | -4,750 | 2026-03-31 |
| 6 | RYTM | RHYTHM PHARMACEUTICALS INC | 689.7K | $60.0M | $68.5M | 3.47% | -5,262 | 2026-03-31 |
| 7 | INSM | INSMED INC | 314.3K | $51.4M | $31.0M | 1.57% | -4,950 | 2026-03-31 |
| 8 | ASND | ASCENDIS PHARMA A/S | 194.0K | $44.4M | $47.3M | 2.40% | -9,500 | 2026-03-31 |
| 9 | XENE | XENON PHARMACEUTICALS INC | 763.0K | $44.4M | $47.8M | 2.43% | -24,768 | 2026-03-31 |
| 10 | TVTX | TRAVERE THERAPEUTICS INC | 1.48M | $43.9M | $82.6M | 4.19% | -732,368 | 2026-03-31 |
| 11 | KYMR | KYMERA THERAPEUTICS INC | 496.9K | $41.4M | $51.4M | 2.61% | -- | 2026-03-31 |
| 12 | PEN | PENUMBRA INC | 120.5K | $39.6M | $38.7M | 1.96% | -- | 2026-03-31 |
| 13 | ISRG | INTUITIVE SURGICAL INC | 82.0K | $37.8M | $29.0M | 1.47% | -- | 2026-03-31 |
| 14 | SRRK | SCHOLAR ROCK HLDG CORP | 739.8K | $36.4M | $35.0M | 1.78% | +6.3K | 2026-03-31 |
| 15 | ELVN | ENLIVEN THERAPEUTICS INC | 826.5K | $32.4M | $45.3M | 2.30% | +28.1K | 2026-03-31 |
| 16 | BSX | BOSTON SCIENTIFIC CORP | 515.3K | $32.3M | $24.1M | 1.22% | +116.3K | 2026-03-31 |
| 17 | IRTC | IRHYTHM HOLDINGS INC | 261.8K | $30.9M | $30.7M | 1.56% | +26.8K | 2026-03-31 |
| 18 | GPCR | STRUCTURE THERAPEUTICS INC | 640.2K | $30.9M | $30.8M | 1.56% | -108,019 | 2026-03-31 |
| 19 | AGIO | AGIOS PHARMACEUTICALS INC | 799.2K | $27.0M | $24.0M | 1.22% | -- | 2026-03-31 |
| 20 | RARE | ULTRAGENYX PHARMACEUTICAL IN | 1.22M | $25.5M | $30.4M | 1.54% | -48,468 | 2026-03-31 |
| 21 | ALNY | ALNYLAM PHARMACEUTICALS INC | 74.0K | $24.5M | $15.2M | 0.77% | +2.8K | 2026-03-31 |
| 22 | COGT | COGENT BIOSCIENCES INC | 624.2K | $24.0M | $24.3M | 1.23% | -224,875 | 2026-03-31 |
| 23 | THC | TENET HEALTHCARE CORP | 125.0K | $23.6M | $31.8M | 1.62% | -- | 2026-03-31 |
| 24 | DXCM | DEXCOM INC | 355.6K | $22.3M | $29.7M | 1.51% | +8.3K | 2026-03-31 |
| 25 | CLDX | CELLDEX THERAPEUTICS INC NEW | 650.3K | $20.6M | $24.7M | 1.26% | -42,268 | 2026-03-31 |
← Scroll →
Page 1 of 4